Chyi‐Chia Richard Lee

Ministry of Health — Malaysia

Medicine · Health Sciences

54h-index16.2kcitations238works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(58), Immune Cell Function and Interaction(33), Immunotherapy and Immune Responses(25), Cancer Immunotherapy and Biomarkers(20), Bladder and Urothelial Cancer Treatments(15)

Publications238 total

684 ATR inhibitor tuvusertib induces immunogenic modulation and sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity which is further enhanced by the IL-15 superagonist N-803
Regular and Young Investigator Award Abstracts·2025Open Access
STING-STAT3-mediated endothelial-mesenchymal transition promotes pulmonary fibrosis in SAVI patients 9089
The Journal of Immunology·2025Open Access
0760 5’-UTR mutation in OXA1L drives cSCC metastasis via tumor dedifferentiation and immune evasion
Journal of Investigative Dermatology·2025Open Access
Paediatric Facial Reconstruction for Psammamatoid Ossifying Fibroma: A Case Report with One-Year Follow-Up
International Journal of Oral and Maxillofacial Surgery·2025
Early recognition of the APECED rash can accelerate the diagnosis of APECED
Clinical Immunology Communications·2024· 4 citedOpen Access
Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne
Annals of the Rheumatic Diseases·2024· 14 citedOpen Access
Calciphylaxis in POEMS syndrome: Case report
Rare·2024· 1 citedOpen Access
APECED Rash as the First Manifestation of APECED Syndrome
Journal of Clinical Immunology·2023· 3 citedOpen Access
Anakinra‐Associated Systemic Amyloidosis
Arthritis & Rheumatology·2023· 10 citedOpen Access
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
Journal of Clinical Investigation·2023· 7 citedOpen Access
Supplementary Data from EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/<i>CDKN1A</i> Expression
2023Open Access
Data from EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/<i>CDKN1A</i> Expression
2023Open Access
Supplementary Data from EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/<i>CDKN1A</i> Expression
2023Open Access
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/<i>CDKN1A</i> Expression
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Data from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Figures 1 - 12 and Tables 1 - 11 from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
Supplementary Materials and Methods from Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Steven A. Rosenberg(8), Michail S. Lionakis(8), Daniel L. Kastner(7), Muthulekha Swamydas(7), John R. Wunderlich(6), Mark Raffeld(6), Edward W. Cowen(6), Massimo Gadina(6), Jean K. Lim(6), Mark E. Dudley(5), Udai S. Kammula(5), Nicholas P. Restifo(5), Raphaela Goldbach‐Mansky(5), Ivona Aksentijevich(5), Philip M. Murphy(5), Paul F. Robbins(4), Deborah L. Stone(4), Steven M. Holland(4), Wanxia Li Tsai(4), Theo Heller(4)